Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

32.260
-1.240-3.70%
Volume:1.08M
Turnover:35.02M
Market Cap:11.94B
PE:-4.60
High:34.240
Open:32.980
Low:31.040
Close:33.500
52wk High:52.900
52wk Low:19.600
Shares:370.00M
HK Float Shares:338.00M
Volume Ratio:0.97
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-7.010
ROE:--
ROA:-12.49%
PB:5.70
PE(LYR):-4.60
PS:79.34

Loading ...

GenFleet Therapeutics (Shanghai) Inc. Announces Revised Articles of Association

Bulletin Express
·
Feb 09

GenFleet (2595) Passes All Resolutions at EGM and Abolishes Supervisory Committee

Bulletin Express
·
Feb 09

GenFleet Therapeutics Held Extraordinary General Meeting

Reuters
·
Feb 09

BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks

Stock News
·
Feb 05

GenFleet Therapeutics (02595) Releases Monthly Return for January 2026

Bulletin Express
·
Feb 05

Bocom International Initiates Coverage on GENFLEET-B (02595) with Buy Rating, HK$51 Target Price

Stock News
·
Jan 23

Genfleet Therapeutics (Shanghai) Inc. Announces Date for Upcoming Extraordinary General Meeting

Reuters
·
Jan 23

GenFleet Therapeutics Shareholders to Vote on Abolishing Supervisory Committee and Amending Articles of Association

Reuters
·
Jan 20

GENFLEET-B (02595) Nears Inclusion in Stock Connect: Stable Trading as Key Factor

Stock News
·
Dec 11, 2025

GENFLEET-B (02595): GFH375 Phase III Trial for Metastatic Pancreatic Cancer Initiated at First Site – World’s First Oral KRAS G12D Inhibitor Monotherapy vs. Chemotherapy Study

Stock News
·
Dec 05, 2025

GenFleet Therapeutics Launches Phase III Trial of Oral KRAS G12D Inhibitor for Metastatic Pancreatic Cancer

Reuters
·
Dec 05, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

GENFLEET-B (02595) Proposes Adoption of H Share Option Scheme and H Share Incentive Plan

Stock News
·
Nov 24, 2025